← Eichor
Study identifier: NCT04934787 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation

Condition: Cerebrovascular Stroke · Foot Drop · Foot Inversion Deformity  ·  Sponsor: The Hong Kong Polytechnic University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

In this work, a novel hybrid ankle-foot robot is designed for gait rehabilitation after stroke, i.e., exoneuromusculoskeleton with balance sensing feedback (ENMS-BSF) by integrating the advantages of soft pneumatic muscle, functional electrical stimulation, exoskeleton and foot balance feedback in one system. With the assistance of the ENMS-BSF the foot drop and foot inversion could be corrected with improved muscle coordination in the paretic lower limb. The device is wearable and light-in-weight for unilateral application during walking. It is hypothesized that with the intervention of the ENMS-BSF the gait pattern of persons after stroke can be improved with long-term rehabilitative effects.

This description comes directly from the study's public registry record.

Talk to the study team

Xiaoling Hu, PhD  ·  34003206  ·  xiaoling.hu@polyu.edu.hk

Cherrie Mok  ·  cherrie.mok@polyu.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

The Hong Kong Polytechnic UniversityHong Kong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04934787